What is the generic name?

DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE

What is the Trade Name for DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE?

NUEDEXTA

What are the Indications for DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE?

• 1 INDICATIONS AND USAGE NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state. PBA is a specific condition, distinct from other types of emotional lability that may occur in patients with neurological disease or injury. NUEDEXTA is a combination product containing dextromethorphan hydrobromide (an uncompetitive NMDA receptor antagonist and sigma-1 agonist) and quinidine sulfate (a CYP450 2D6 inhibitor) indicated for the treatment of pseudobulbar affect (PBA). ( 1 )

References: https://open.fda.gov/